510(k) device
XenMatrix AB Surgical Graft
C. R. Bard · Collagen Surgical Mesh Containing Drugs (PIJ, Class II) · First FDA decision Sep 19, 2014, newest Dec 23, 2016Hernia
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
3
Naming "XenMatrix AB"
MAUDE reports
86
Brand "XenMatrix AB", since 2015
PubMed studies
5
Mentioning "XenMatrix AB"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing XenMatrix AB Surgical Graft
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K162193 · Decided Dec 23, 2016 · 141 days after receipt
Device type: Collagen Surgical Mesh Containing Drugs (PIJ) · General & Plastic Surgery
K151177 · Decided Jul 30, 2015 · 90 days after receipt
Device type: Collagen Surgical Mesh Containing Drugs (PIJ) · General & Plastic Surgery
K133223 · Decided Sep 19, 2014 · 333 days after receipt
Device type: Collagen Surgical Mesh Containing Drugs (PIJ) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "XenMatrix AB", any status and sponsor, newest update first.
Jeffrey JanisAcademic, hospital or other
NCT02228889 · 46 participants · Start Jan 2015 · Primary completion Mar 27, 2025
Device: Strattice; XenMatrix · For: Hernia, Ventral; Intestinal Fistula; Fibromatosis, Abdominal
Sites: Columbus, Ohio
J. Peter Rubin, MDAcademic, hospital or other
NCT04051242 · 10 participants · Start Feb 10, 2020 · Primary completion Jan 24, 2024
Device: XenMatrix™ AB Surgical Graft · For: Muscle Loss
Sites: Pittsburgh, Pennsylvania
C. R. BardPublic (BDX)
NCT02691962 · 75 participants · Start May 2016 · Primary completion May 2020
Device: Xen Matrix AB · For: Incisional Hernia
Sites: Los Angeles, California; San Francisco, California; Atlanta, Georgia · 11 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "XenMatrix AB", and for the whole product code for context.
This brand
86 reports: 6 malfunction, 76 injury, 4 death
Whole product code PIJ
83 reports: 5 malfunction, 74 injury, 4 death
Newest reports for this brand
- XenMatrix ABInjury
Davol Inc., Sub. C.R. Bard, Inc. -1213643
1213643-2026-01150 · Received Sep 3, 2026 · Event dated Jul 18, 2019
Device type: Mesh, Surgical (FTM)
Device problem as coded: Material Deformation
Patient problem as coded: Adhesion(s); Bacterial Infection; Pain; Hernia; Obstruction/Occlusion
- XenMatrix ABInjury
Davol Inc., Sub. C.R. Bard, Inc. -1213643
1213643-2026-00944 · Received Jul 27, 2026 · Event dated Apr 7, 2021
Device type: Collagen Surgical Mesh Containing Drugs (PIJ)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Abdominal Pain; Unspecified Infection; Seroma; Impaired Healing
- XENMATRIX ABInjury
DAVOL INC., SUB. C.R. BARD, INC. -1213643
1213643-2026-00678 · Received May 27, 2026 · Event dated Jul 30, 2020
Device type: Collagen Surgical Mesh Containing Drugs (PIJ)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Scar Tissue; Hernia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "XenMatrix AB"[tiab]. The summary above synthesizes these.
- Comparison of Antibiotic-Coated versus Uncoated Porcine Dermal Matrix.
Cohen LE, Imahiyerobo TA, Scott JR, et al. · Plast Reconstr Surg · 2016Comparative Study, Evaluation Study
- Early Clinical Outcomes of a Novel Antibiotic-Coated, Non-Crosslinked Porcine Acellular Dermal Graft after Complex Abdominal Wall Reconstruction.
Baker EH, Lepere D, Lundgren MP, et al. · J Am Coll Surg · 2016Multicenter Study, Research Support, Non-U.S. Gov't
- Prospective, multicenter study of antimicrobial-coated, noncrosslinked, acellular porcine dermal matrix (XenMatrixࡊ AB Surgical Graft) for hernia repair in all centers for disease control and prevention wound classes: 24-month follow-up cohort.
Ilahi ON, Velmahos G, Janis JE, et al. · Ann Med Surg (Lond) · 2023
- Long-Term Clinical Outcomes of an Antibiotic-Coated Non-Cross-linked Porcine Acellular Dermal Graft for Abdominal Wall Reconstruction for High-Risk and Contaminated Wounds.
Robinson J, Sulzer JK, Motz B, et al. · Am Surg · 2022
- Evaluation of the Antimicrobial Efficacy of a Novel Rifampin/Minocycline-Coated, Noncrosslinked Porcine Acellular Dermal Matrix Compared With Uncoated Scaffolds for Soft Tissue Repair.
Majumder A, Scott JR, Novitsky YW · Surg Innov · 2016Comparative Study, Evaluation Study
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.